Back
Protagonist Therapeutics Vs. Inhibrx(DELISTED) Industry Stock Comparison
Sell
45
PTGX
Protagonist Therapeutics
Last Price:
31.21
Seasonality Move:
-0.18%
Sell
41
INBX:DL
Inhibrx(DELISTED)
Last Price:
30.63
Seasonality Move:
34.15%
Sell
45
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $31.71. The Score for PTGX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Inhibrx(DELISTED) (INBX:DL)
is a Sell
Is Inhibrx(DELISTED) a Buy, Sell or Hold?
- The current Inhibrx(DELISTED) [INBX:DL] share price is $30.63. The Score for INBX:DL is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- INBX:DL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $31.71
The current trend is moderately bearish and PTGX is experiencing slight selling pressure.
INBX:DL Stock Price Chart
What is Inhibrx(DELISTED)'s stock price today?
-
The Inhibrx(DELISTED) share price today is $30.63
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INBX:DL is experiencing slight buying pressure.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.74 | Buy |
| Relative Strength Index (14 RSI): | 51.21 | Buy |
| Chaikin Money Flow: | -137490 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.68 - 33.74) | Sell |
| Bollinger Bands (100): | (26.43 - 31.41) | Buy |
INBX:DL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.37 | Sell |
| Relative Strength Index (14 RSI): | 18.16 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.39 - 34.87) | Sell |
| Bollinger Bands (100): | (33.91 - 37.15) | Sell |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.52 | Sell |
| 20-day SMA: | 31.85 | Sell |
| 50-day SMA: | 29.34 | Buy |
| 200-day SMA: | 23.96 | Buy |
| 8-day EMA: | 32.27 | Sell |
| 20-day EMA: | 31.89 | Sell |
| 50-day EMA: | 30.33 | Buy |
| 200-day EMA: | 25.81 | Buy |
INBX:DL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.82 | Sell |
| 20-day SMA: | 34.13 | Sell |
| 50-day SMA: | 34.45 | Sell |
| 200-day SMA: | 28.52 | Buy |
| 8-day EMA: | 33.46 | Sell |
| 20-day EMA: | 33.98 | Sell |
| 50-day EMA: | 34.35 | Sell |
| 200-day EMA: | 30.69 | Sell |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $2.69 per share, an increase this year of $4.32 per share, and a decrease next year of $2.45 per share.
Inhibrx(DELISTED) Earnings Growth & INBX:DL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Protagonist Therapeutics Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Inhibrx(DELISTED) Technical Analysis
| May 28 | May 29 | May 30 | |
|---|---|---|---|
| May | |||
| 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | |||
| 8-day SMA: | |||
| 20-day SMA: | |||
| 50-day SMA: | |||
| 200-day SMA: | |||
| 8-day EMA: | |||
| 20-day EMA: | |||
| 50-day EMA: | |||
| 200-day EMA: | |||
| MACD (12, 26): | |||
| Relative Strength Index (14 RSI): | |||
| Bollinger Bands (25): | |||
| Bollinger Bands (100): | |||